AtaiBeckley (ATAI) Equity Average (2021 - 2026)
AtaiBeckley (ATAI) recorded quarterly Equity Average of $210.3 million in Q1 2026.
AtaiBeckley (ATAI) Equity Average (2021 - 2026) Analysis & Trends
AtaiBeckley has disclosed Equity Average across 5 years of filings, most recently posting $151.8 million for Q3 2025.
- Equity Average for Q3 2025 came in at $151.8 million, down 3.35% year-over-year; the trailing twelve-month figure through Sep 2025 was $151.8 million (down 3.35% YoY), and the FY2024 annual result was $180.3 million, down 29.3% from the prior year.
- Equity Average came in at $151.8 million for Q3 2025 at AtaiBeckley, up from $148.0 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $469.0 million in Q3 2021 to a low of $131.3 million in Q4 2024.
- The 5-year median for Equity Average is $233.4 million (2024), against an average of $253.9 million.
- Peak annual rise in Equity Average reached 3.35% in 2025, while the deepest fall reached 42.52% in 2025.
- AtaiBeckley's Equity Average stood at $415.0 million in 2021, then tumbled by 32.32% to $280.9 million in 2022, then retreated by 18.79% to $228.1 million in 2023, then tumbled by 42.44% to $131.3 million in 2024, then grew by 15.64% to $151.8 million in 2025.
- The last three Equity Average figures came in at $151.8 million (Q3 2025), $148.0 million (Q2 2025), and $134.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 210.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210.34 Mn |
| Sep 30, 2025 | 151.84 Mn |
| Jun 30, 2025 | 147.99 Mn |
| Mar 31, 2025 | 134.18 Mn |
| Dec 31, 2024 | 131.31 Mn |
| Sep 30, 2024 | 157.10 Mn |
| Jun 30, 2024 | 195.22 Mn |
| Mar 31, 2024 | 233.43 Mn |
| Jun 30, 2023 | 228.14 Mn |
| Mar 31, 2023 | 253.20 Mn |
| Dec 31, 2022 | 280.92 Mn |
| Sep 30, 2022 | 308.10 Mn |
| Jun 30, 2022 | 337.24 Mn |
| Mar 31, 2022 | 365.63 Mn |
| Dec 31, 2021 | 415.05 Mn |
| Sep 30, 2021 | 469.04 Mn |